Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Hedner

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
Blood Pressure|March 17, 2011
Treatment of high blood pressure in acute stroke--the SCAST studySverre E Kjeldsen, Thomas Hedner, Krzysztof Narkiewicz, et al.
Blood Pressure|January 24, 2012
Increased time varying heart rate and cardiovascular risk in hypertension: benefit of selective I((f)) channel inhibitor?Sverre E Kjeldsen, Thomas Hedner, Krzysztof Narkiewicz, et al.
Blood Pressure|July 31, 2008
More is less? Optimal combination therapy for adequate blood pressure lowering in hypertensionSverre E Kjeldsen, Thomas Hedner, Krzystof Narkiewicz, et al.
Blood Pressure|June 2, 2009
Does GISSI-AF change the concept of using RAS inhibitors in the primary prevention of atrial fibrillation in hypertensive patients?Sverre E Kjeldsen, Suzanne Oparil, Thomas Hedner, et al.
Blood Pressure|September 28, 2012
Direct renin inhibitors in hypertension - approaching the moment of truthThomas Hedner, Krzysztof Narkiewicz, Suzanne Oparil, et al.
Blood Pressure|March 18, 2005
Renal hypertensive target organ damage--new evidence emerges in diabetics and smokersSverre E Kjeldsen, Ingrid Os, Thomas Hedner, et al.
Blood Pressure|March 27, 2007
The question of whether diabetes and its cardiovascular risks can be prevented: a realistic DREAM?Thomas Hedner, Krzysztof Narkiewicz, Suzanne Oparil, et al.
Blood Pressure|June 24, 2008
Urgent need to address quality control issues of out-of-office blood pressure measurement and patient risk assessmentThomas Hedner, Sverre E Kjeldsen, Krzysztof Narkiewicz, et al.
Blood Pressure. Supplement|August 19, 2008
Achieving better blood pressure controlThomas Hedner, Suzanne Oparil, Krzysztof Narkiewicz, et al.
Blood Pressure|October 15, 2015
The J-curve phenomenon revisited again: SPRINT outcomes favor target systolic blood pressure below 120 mmHgSverre E Kjeldsen, Suzanne Oparil, Krzysztof Narkiewicz, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Blood Pressure|March 17, 2011
Treatment of high blood pressure in acute stroke--the SCAST studySverre E Kjeldsen, Thomas Hedner, Krzysztof Narkiewicz, et al.
Blood Pressure|January 24, 2012
Increased time varying heart rate and cardiovascular risk in hypertension: benefit of selective I((f)) channel inhibitor?Sverre E Kjeldsen, Thomas Hedner, Krzysztof Narkiewicz, et al.
Blood Pressure|July 31, 2008
More is less? Optimal combination therapy for adequate blood pressure lowering in hypertensionSverre E Kjeldsen, Thomas Hedner, Krzystof Narkiewicz, et al.
Blood Pressure|June 2, 2009
Does GISSI-AF change the concept of using RAS inhibitors in the primary prevention of atrial fibrillation in hypertensive patients?Sverre E Kjeldsen, Suzanne Oparil, Thomas Hedner, et al.
Blood Pressure|September 28, 2012
Direct renin inhibitors in hypertension - approaching the moment of truthThomas Hedner, Krzysztof Narkiewicz, Suzanne Oparil, et al.
Blood Pressure|March 18, 2005
Renal hypertensive target organ damage--new evidence emerges in diabetics and smokersSverre E Kjeldsen, Ingrid Os, Thomas Hedner, et al.
Blood Pressure|March 27, 2007
The question of whether diabetes and its cardiovascular risks can be prevented: a realistic DREAM?Thomas Hedner, Krzysztof Narkiewicz, Suzanne Oparil, et al.
Blood Pressure|June 24, 2008
Urgent need to address quality control issues of out-of-office blood pressure measurement and patient risk assessmentThomas Hedner, Sverre E Kjeldsen, Krzysztof Narkiewicz, et al.
Blood Pressure. Supplement|August 19, 2008
Achieving better blood pressure controlThomas Hedner, Suzanne Oparil, Krzysztof Narkiewicz, et al.
Blood Pressure|October 15, 2015
The J-curve phenomenon revisited again: SPRINT outcomes favor target systolic blood pressure below 120 mmHgSverre E Kjeldsen, Suzanne Oparil, Krzysztof Narkiewicz, et al.
Pageof 13